Previous studies in humans with type 1 diabetes (T1D) and in non-obese diabetic mice have investigated the beneficial immunomodulatory potential of aerobic physical activity. Performing high volume of aerobic exercise may favorably regulate autoimmunity in diabetes. We tested whether increased physical activity is a self-sufficient positive factor in T1D subjects. During a 3-month observational period, active (6M; 40.5±6.1 years; BMI 24.5±2.1) and sedentary (4M, 3F; 35.9±8.9 years; BMI 25.7±3.8) T1D individuals on insulin pump therapy were studied for metabolic, inflammatory and autoimmune parameters. At baseline and at the end of a 3-month period, glycosylated hemoglobin (HbA1c), auto-antibodies (anti-GAD, anti-ZnT8, anti-IA2, ICA) and pro-inflammatory cytokines (IL-6 and TNF-α) were evaluated. During the 3rd month of the period, physically active T1D patients showed a significant reduction in the average glucose levels (-9%, p=0.025, by CGM) compared to the 1st-month values, and even their hyperglycemic episodes (>180mg/dL) diminished significantly (-24.2%, p=0.032 vs 1st month). Moreover, active T1D subjects exhibited an improved body composition with respect to sedentary controls. No significant changes were detected as to the autoimmune and inflammatory profiles. This study confirms the beneficial role of physical exercise associated with insulin pump therapy in order to improve metabolic control in individuals with T1D. These preliminary positive observations need to be challenged in a prolonged interventional follow-up.

Active Subjects with Autoimmune Type 1 Diabetes Have Better Metabolic Profiles than Sedentary Controls / M. Adamo, R. Codella, F. Casiraghi, A. Ferrulli, C. Macrì, E. Bazzigaluppi, I. Terruzzi, L. Inverardi, C. Ricordi, L. Luzi. - In: CELL TRANSPLANTATION. - ISSN 0963-6897. - 26:1(2017 Jan), pp. 23-32. ((Intervento presentato al 76. convegno Scientific Congress American Diabetes Association tenutosi a New Orleans (USA) nel 2016 [10.3727/096368916X693022].

Active Subjects with Autoimmune Type 1 Diabetes Have Better Metabolic Profiles than Sedentary Controls

R. Codella
Secondo
;
A. Ferrulli;I. Terruzzi;L. Luzi
2017

Abstract

Previous studies in humans with type 1 diabetes (T1D) and in non-obese diabetic mice have investigated the beneficial immunomodulatory potential of aerobic physical activity. Performing high volume of aerobic exercise may favorably regulate autoimmunity in diabetes. We tested whether increased physical activity is a self-sufficient positive factor in T1D subjects. During a 3-month observational period, active (6M; 40.5±6.1 years; BMI 24.5±2.1) and sedentary (4M, 3F; 35.9±8.9 years; BMI 25.7±3.8) T1D individuals on insulin pump therapy were studied for metabolic, inflammatory and autoimmune parameters. At baseline and at the end of a 3-month period, glycosylated hemoglobin (HbA1c), auto-antibodies (anti-GAD, anti-ZnT8, anti-IA2, ICA) and pro-inflammatory cytokines (IL-6 and TNF-α) were evaluated. During the 3rd month of the period, physically active T1D patients showed a significant reduction in the average glucose levels (-9%, p=0.025, by CGM) compared to the 1st-month values, and even their hyperglycemic episodes (>180mg/dL) diminished significantly (-24.2%, p=0.032 vs 1st month). Moreover, active T1D subjects exhibited an improved body composition with respect to sedentary controls. No significant changes were detected as to the autoimmune and inflammatory profiles. This study confirms the beneficial role of physical exercise associated with insulin pump therapy in order to improve metabolic control in individuals with T1D. These preliminary positive observations need to be challenged in a prolonged interventional follow-up.
continuous glucose monitoring; insulin pump therapy; physical activity; type 1 diabetes
Settore M-EDF/02 - Metodi e Didattiche delle Attivita' Sportive
Settore MED/13 - Endocrinologia
   Immunomodulatory Effects of Exercise in Type 1 Diabetes
   IMMEEDIA
   EUROPEAN COMMISSION
   FP7
   247472
gen-2017
20-set-2016
Article (author)
File in questo prodotto:
File Dimensione Formato  
ct-1653_luzi_et_al_1474367550642.pdf

accesso riservato

Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 602.47 kB
Formato Adobe PDF
602.47 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
AdamoEtAlii_CellTransplant_Active_2017.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 350.01 kB
Formato Adobe PDF
350.01 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/450553
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 27
  • ???jsp.display-item.citation.isi??? 23
social impact